Amylyx’s bet on a GLP-1 blocker pays off
admin Boston-area biopharmaceutical company Amylyx Pharmaceuticals has reported overwhelmingly positive results from a pivotal Phase 3...
fda
Leo Pharma Bolsters Rare Dermatology Portfolio with Acquisition of Dersimelagon, an Oral Therapy for Severe Sunlight Sensitivity.
Copenhagen, Denmark — Leo Pharma A/S, a global leader in medical dermatology, has significantly expanded...
Biopharma Industry Sees Breakthroughs in Lung Cancer, Biosimilar Deals, Legal Battles, and Strategic Partnerships
The biopharmaceutical landscape continues to evolve rapidly, marked by significant advancements in oncology, strategic collaborations...
BioMarin Bolsters Pipeline with Alesta Acquisition, Targeting Broad Patient Population in Muscle and Skeletal Diseases
BioMarin Pharmaceutical Inc. announced on August 18, 2026, the acquisition of Alesta Therapeutics, a Netherlands-based...
Dr. Heidi Overton Nominated to Key Role Amidst FDA Turmoil, Sparking Industry Uncertainty
The Trump administration has announced the nomination of Dr. Heidi Overton, a medical doctor, veteran...
Zipalertinib Emerges as Potent Challenger in EGFR Exon 20 NSCLC Treatment Landscape, Setting New Standards for Efficacy and Market Competition.
In a significant development for oncology, Taiho Oncology and Cullinan Therapeutics have announced compelling positive...
America’s Biotech Renaissance: Regional Hubs Emerge as Billions in Pharma Manufacturing Investment Reshape Economic Landscape
As pharmaceutical manufacturing investment experiences an unprecedented surge, a concerted effort from state and federal...
Biopharma Sector Buzzes with Regulatory Breakthroughs, Patent Disputes, and Strategic Deals
The biopharmaceutical landscape has been particularly dynamic this week, marked by significant regulatory developments, high-stakes...
Zenbexus Clearance Marks New Era for Bristol Myers Squibb’s Multiple Myeloma Franchise
The U.S. Food and Drug Administration (FDA) has granted clearance to Zenbexus, a novel protein-degrading...
Lilly files six lawsuits in bid to shut down ‘black market’ for retatrutide
Pharmaceutical giant Eli Lilly and Company has significantly escalated its multi-front battle against the widespread...
